Glenmark

Cipla and Glenmark Drug Recall in US Over Manufacturing Issues

Indian pharmaceutical giants Cipla and Glenmark, who are prominent players in the pharmaceutical industry, have reportedly recalled their products from the American market due to manufacturing irregularities in the products, as reported by the US Food and Drug Administration (USFDA). The report highlighted the ongoing challenges in pharmaceutical production and...

Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular 10,11 anti-diabetic drug, Liraglutide, for the first time in India. The drug is being marketed under the brand name Lirafit™ following the approval from the Drug Controller General of India (DCGI). Priced at around...

Glenmark launches injection for prevention of chemotherapy-induced nausea, vomiting in India

Glenmark Pharmaceuticals announced on Monday that it was the first pharmaceutical company in India to launch Akynzeo, an intravenous injection formulation for the prevention of chemotherapy-induced nausea and vomiting (CINV), under an exclusive licencing agreement with Helsinn, a Swiss biopharma group company. It is a ready-to-dilute IV injection that contains...